Prostate Specific Antigen Method
FDA 510(k) K973101 · Dade Chemistry Systems, Inc.
510(k) numberK973101
Submission
- Device name
- Prostate Specific Antigen Method
- Applicant
- Dade Chemistry Systems, Inc.
Newark, DE, US - Received
- August 19, 1997
- Decision date
- September 18, 1997
- Decision
- Substantially Equivalent (SESE)
- Type
- Traditional 510(k)
- Summary
- 510(k) summary available from FDA
Device classification
- Product code
- LTJ – Prostate-Specific Antigen (Psa) For Management Of Prostate Cancers
- Device class
- Class II (moderate risk)
- Regulation
- 21 CFR 866.6010
- Specialty
- Immunology
Other 510(k)s with product code LTJ
| 510(k) | Device | Applicant | Decision |
|---|---|---|---|
| K251630 | Atellica IM Total PSA II (tPSAII)LTJ · Traditional | Siemens Healthcare Diagnostics, Inc. | 01/05/2026SE |
| K162378 | FREND PSA PLUS (reagent cartridge)LTJ · Traditional | Nanoentek USA, Inc. | 05/17/2017SE |
| K124056 | Frend Psa Plus (Reagent Cartridge)LTJ · Traditional | Nanoentek, Inc. | 05/29/2013SE |
| K031343 | Tpsa Flex Reagent CartridgeLTJ · Special | Dade Behring, Inc. | 05/15/2003SE |
| K022288 | Complexed Prostate Specific Antigen (Cpsa) Assay for the Bayer Advia Integrated Module…LTJ · Traditional | Bayer Corp. | 12/17/2002SE |
| K022177 | Prostate Specific Antigen (Psa) Assay for the Advia Integrated Modular SystemLTJ · Traditional | Bayer Diagnostics Corp. | 12/17/2002SE |
| K010550 | Vidas Total Prostate Specific Antigen (Tpsa), Model 30 428LTJ · Traditional | bioMerieux, Inc. | 04/24/2001SE |
| K003963 | Dimension Psa Flex Reagent CartridgeLTJ · Traditional | Dade Behring, Inc. | 02/28/2001SE |
| K002376 | Advia: Centaur and Acs: 180 Cpsa AssayLTJ · Traditional | Bayer Corp. | 10/26/2000SE |
| K003094 | Fastpack Psa Immunoassay, Fastpack AnalyzerLTJ · Special | Qualigen, Inc. | 10/25/2000SE |
More from Qualigen, Inc.
| 510(k) | Device | Decision |
|---|---|---|
| K973650 | Troponin (Trop) MethodMMI · Traditional | 10/20/1997SE |
| K973100 | Prostate Specific Antigen (Psa) CalibratorJIT · Traditional | 09/29/1997SE |
| K973099 | Prostate Specific Antigen ControlJJX · Traditional | 09/29/1997SE |
| K971141 | FT4 Method for the Dimension RXL Clinical Chemistry SystemCEC · Traditional | 04/28/1997SE |
| K970387 | Human Chorionic Gonadotropin MethodDHA · Traditional | 03/10/1997SE |
| K970393 | Thyroid Stimulating Hormone MethodJLW · Traditional | 03/03/1997SE |
| K970336 | MMB CalibratorJIT · Traditional | 03/03/1997SE |
| K970396 | Human Chorionic Gonadotropin CalibratorJIW · Traditional | 02/20/1997SE |
| K970389 | Thyroid CalibratorJIT · Traditional | 02/18/1997SE |
| K970343 | MMB MethodJHY · Traditional | 02/14/1997SE |
Questions and answers
When was Prostate Specific Antigen Method cleared by the FDA?
Prostate Specific Antigen Method (K973101) received a 510(k) decision of Substantially Equivalent on September 18, 1997, 30 days after the submission was received.
What is the product code of K973101?
The FDA product code is LTJ – Prostate-Specific Antigen (Psa) For Management Of Prostate Cancers, a Class II (moderate risk) device regulated under 21 CFR 866.6010.